Susan Salka - McKesson Independent Director
| MCK Stock | USD 562.78 7.29 1.28% |
Director
Ms. Susan R. Salka is an Independent Director of the Company. Ms. Salka, age 53, has served as Chief Executive Officer and President of AMN Healthcare Services, Inc., the leader in providing healthcare workforce solutions and staffing services to healthcare facilities across the nation, since 2005, and a director of the company since 2003. She has served in several other executive roles since joining AMN Healthcare Services, Inc. in 1990, including Chief Operating Officer, Chief Financial Officer and Senior Vice President of Business Development. She was formerly a director of Beckman Coulter Inc. and Playtex Products. Ms. Salka was a director of the Company since October 2014. With over 30 years of experience in the healthcare services industry, Ms. Salka brings to the Board a deep understanding of emerging trends in healthcare services. This industry experience gives her insight into important aspects of the Companys businesses, including opportunities potentially available to those businesses. She has also served in a number of executive leadership positions, including as a Chief Executive Officer, Chief Financial Officer and Chief Operating Officer, which have provided her with business management, operational, financial and longrange planning experience. Ms. Salka also brings valuable experience acquired through significant public company board service. since 2014.
| Age | 56 |
| Tenure | 10 years |
| Address | 6555 State Highway 161, Irving, TX, United States, 75039 |
| Phone | 972 446 4800 |
| Web | https://www.mckesson.com |
Susan Salka Latest Insider Activity
Tracking and analyzing the buying and selling activities of Susan Salka against McKesson stock is an integral part of due diligence when investing in McKesson. Susan Salka insider activity provides valuable insight into whether McKesson is net buyers or sellers over its current business cycle. Note, McKesson insiders must abide by specific rules, including filing SEC forms every time they buy or sell McKesson'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Susan Salka over six months ago Disposition of tradable shares by Susan Salka of McKesson at 554.61 subject to Rule 16b-3 |
McKesson Management Efficiency
The company has Return on Asset of 0.0392 % which means that on every $100 spent on assets, it made $0.0392 of profit. This is way below average. McKesson's management efficiency ratios could be used to measure how well McKesson manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is expected to rise to 0.27 this year, although the value of Return On Tangible Assets will most likely fall to 0.04. At this time, McKesson's Total Current Liabilities is quite stable compared to the past year. Non Current Liabilities Total is expected to rise to about 17.5 B this year, although the value of Liabilities And Stockholders Equity will most likely fall to about 36.5 B.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Bruce Downey | Cardinal Health | 72 | |
| Eddie Moore | Owens Minor | 71 | |
| Patricia Hall | Cardinal Health | 67 | |
| Steven Paladino | Henry Schein | 67 | |
| Nancy Killefer | Cardinal Health | 66 | |
| Colleen Arnold | Cardinal Health | 61 | |
| Carrie Cox | Cardinal Health | 62 | |
| John Losh | Cardinal Health | 73 | |
| Mark Mlotek | Henry Schein | 68 | |
| Akhil Johri | Cardinal Health | 59 | |
| Gwendolyn Bingham | Owens Minor | 61 | |
| Trudi Allcott | Owens Minor | N/A | |
| Michael Riordan | Owens Minor | 61 | |
| Mark McGettrick | Owens Minor | 63 | |
| Calvin Darden | Cardinal Health | 69 | |
Management Performance
| Return On Asset | 0.0392 |
McKesson Leadership Team
Elected by the shareholders, the McKesson's board of directors comprises two types of representatives: McKesson inside directors who are chosen from within the company, and outside directors, selected externally and held independent of McKesson. The board's role is to monitor McKesson's management team and ensure that shareholders' interests are well served. McKesson's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, McKesson's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lori Schechter, Executive Vice President Chief Compliance Officer, General Counsel | ||
| Holly Weiss, VP Relations | ||
| Pete Slone, Senior Affairs | ||
| W Dunbar, Independent Director | ||
| Bradley Lerman, Independent Director | ||
| LeAnn Smith, Executive Officer | ||
| Kenneth Washington, Independent Director | ||
| M Jacobs, Independent Director | ||
| Kirk Kaminsky, President Business | ||
| Edward Mueller, Independent Chairman of the Board | ||
| Nancy Avila, Chief VP | ||
| James Hinton, Director | ||
| Richard Carmona, Independent Director | ||
| Marie Knowles, Independent Director | ||
| N Coles, Independent Director | ||
| Linda Mantia, Independent Director | ||
| Nancy Flores, Executive Vice President, Chief Technology Officer, Chief Information Officer | ||
| Tracy Faber, Chief Human Resource Officer, Executive Vice President | ||
| Susan Salka, Independent Director | ||
| Kevin Emerson, Interim Senior Vice President Chief Accounting Officer, Controller | ||
| Tom Rodgers, Executive Vice President and Chief Strategy and Business Development Officer | ||
| Paul Smith, Senior Taxes | ||
| Donald Knauss, Independent Director | ||
| Maria Martinez, Independent Director | ||
| Michele JD, Executive Officer | ||
| Brad Lerman, Independent Director | ||
| Kathleen Thompson, Director | ||
| Rachel Rodriguez, Vice Relations | ||
| Michele Lau, Executive Officer | ||
| Britt Vitalone, Chief Financial Officer, Executive Vice President | ||
| Thomas MBA, Executive Officer | ||
| Britt CPA, Executive CFO | ||
| Napoleon Rutledge, Senior Vice President Chief Accounting Officer, Controller | ||
| Francisco Fraga, Chief VP | ||
| Brian Tyler, President, Chief Executive Officer, Chief Operating Officer, Director | ||
| MChristine Jacobs, Independent Director | ||
| Lori JD, Board Advisor | ||
| Dominic Caruso, Independent Director |
McKesson Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is McKesson a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | 0.0392 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 77.07 B | ||||
| Shares Outstanding | 126.94 M | ||||
| Shares Owned By Insiders | 0.09 % | ||||
| Shares Owned By Institutions | 89.08 % | ||||
| Number Of Shares Shorted | 1.91 M | ||||
| Price To Earning | 26.98 X | ||||
| Price To Book | 5.04 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in McKesson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy McKesson Stock please use our How to buy in McKesson Stock guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of McKesson. If investors know McKesson will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about McKesson listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.62) | Dividend Share 2.57 | Earnings Share 19.1 | Revenue Per Share 2.5 K | Quarterly Revenue Growth 0.213 |
The market value of McKesson is measured differently than its book value, which is the value of McKesson that is recorded on the company's balance sheet. Investors also form their own opinion of McKesson's value that differs from its market value or its book value, called intrinsic value, which is McKesson's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because McKesson's market value can be influenced by many factors that don't directly affect McKesson's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between McKesson's value and its price as these two are different measures arrived at by different means. Investors typically determine if McKesson is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, McKesson's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.